Sellas Life Sciences Group Inc (SLS)
SBC to Revenue
0.00%
Quarterly · Period ending:
SLS SBC to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
SLS Quarterly SBC/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
SLS sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 37.5% | |
| 0% | |
| 0% | |
| 13.8947% | |
| 3.2281% | |
| 7.4211% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -9.7358% | |
| 0% | |
| 19.0716% | |
| 22.8% | |
| 29.7966% | |
| 80.1852% | |
| 64.9078% | |
| 74.6894% | |
| 90.0532% | |
| 62.3077% | |
| 0% | |
| 0% | |
| 28.8564% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 374.4856% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |